Synthesis of thrombin-inhibiting heparin mimetics without side effects

[1]  J. Herbert,et al.  First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin. , 1998, Angewandte Chemie.

[2]  B. Chong,et al.  Heparin-induced Thrombocytopenia: Towards Consensus , 1998, Thrombosis and Haemostasis.

[3]  J. Abrahams,et al.  The anticoagulant activation of antithrombin by heparin. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Thomas,et al.  Does Low Molecular Weight Heparin Cause Less Bleeding? , 1997, Thrombosis and Haemostasis.

[5]  J. Herbert,et al.  Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540). , 1997, Journal of medicinal chemistry.

[6]  J. Herbert,et al.  Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin. , 1996, Circulation research.

[7]  P. Grootenhuis,et al.  Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity , 1995, Nature Structural Biology.

[8]  W. Bode,et al.  The clot thickens: clues provided by thrombin structure. , 1995, Trends in biochemical sciences.

[9]  C. V. van Boeckel,et al.  Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide. , 1994, Bioorganic & medicinal chemistry.

[10]  S. Olson,et al.  Regulation of Thrombin Activity by Antithrombin and Heparin , 1994, Seminars in thrombosis and hemostasis.

[11]  M. Petitou,et al.  The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics , 1993 .

[12]  U. Lindahl,et al.  Mode of interaction between platelet factor 4 and heparin. , 1993, Glycobiology.

[13]  C. V. Boeckel,et al.  Biologically active heparin-like fragments with a “non-glycosamino”glycan structure. Part 3 : o-alkylated-o-sulphated pentasaccharides. , 1992 .

[14]  H. Halvorson,et al.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.

[15]  D. Atha,et al.  Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. , 1987, Biochemistry.

[16]  Å. Danielsson,et al.  Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. , 1986, The Journal of biological chemistry.

[17]  J. Kelton,et al.  A diagnostic test for heparin-induced thrombocytopenia , 1986 .

[18]  B. Casu,et al.  Structure and biological activity of heparin. , 1985, Advances in carbohydrate chemistry and biochemistry.

[19]  D. Lane,et al.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4. , 1984, The Biochemical journal.

[20]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[21]  J. Fareed,et al.  Studies on a highly active anticoagulant fraction of high molecular weight isolated from porcine sodium heparin. , 1982, Thrombosis research.

[22]  H. Paulsen.  Advances in Selective Chemical Syntheses of Complex Oligosaccharides , 1982 .

[23]  D. Beeler,et al.  Multiple functional domains of the heparin molecule. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Höök,et al.  The molecular-weight-dependence of the anti-coagulant activity of heparin. , 1978, The Biochemical journal.

[25]  T. Umetsu,et al.  Effect of 1-Methyl-2-Mercapto-5-(3-Pyridyl)-Imidazole (KC-6141), an Anti-Aggregating Compound, on Experimental Thrombosis in Rats , 1978, Thrombosis and Haemostasis.